BIO-RAD laboratories:1110109 [15-015045]
Ended Awarded Last action
- Contract number
- HHSN26100019
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,337
Award facts
- Contract value 100% obligated
- $1,337.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,039 | |
| Original award | $8,376 |
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a $1,337.42 firm fixed-price blanket purchase agreement (BPA) call from the National Cancer Institute on January 20, 2015, with an ultimate completion date of February 9, 2016. This award was not designated as a small business set-aside. The contract was performed in Bethesda, Maryland, and represents a call order under Bio-Rad's broader purchasing agreement with the National Institutes of Health. Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, headquartered in Hercules, California, and specializes in advanced scientific instrumentation, laboratory equipment, reagents, and consumables. The company's Life Science Group Division provides cutting-edge laboratory technologies including polymerase chain reaction systems, thermal cyclers, droplet digital PCR instruments, gel imaging systems, and specialized diagnostic reagents.
This contract call reflects Bio-Rad's established position as a critical federal supplier of sophisticated research instrumentation to the National Cancer Institute and broader National Institutes of Health network. The company maintains a significant $10 million single-award BPA with the NIH Office of Logistics and Acquisition Operations, valid through December 31, 2025, which enables procurement of biological materials, blood products, chemicals, laboratory supplies, and medical/surgical supplies. Bio-Rad's federal contracting history demonstrates consistent awards across multiple agencies including the Centers for Disease Control and Prevention, Food and Drug Administration, Department of Agriculture, Department of Veterans Affairs, and Department of Defense, primarily for specialized laboratory instruments and associated consumables supporting research and diagnostic capabilities.
Quick answers
Who was awarded contract HHSN26100019?
HHSN26100019 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on January 20, 2015.
How much is contract HHSN26100019 worth?
The government has obligated $1,337 on HHSN26100019.
Is contract HHSN26100019 an order under another contract?
Yes. HHSN26100019 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100019 competed?
The extent of competition for HHSN26100019 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award